Article Abstract
The 3 new antipsychotics—risperidone, olanzapine, and quetiapine—are transforming the treatment of schizophrenia and other psychotic illnesses. These new atypical antipsychotic agents have now replaced so-called conventional antipsychotics such as haloperidol and chlorpromazine because clinical trials confirm that atypical antipsychotics have a better safety and efficacy profile than conventional antipsychotics. Clinical experience reveals that some patients respond better to one of these agents than to another, sometimes dramatically.
Download Free PDF
This PDF is free for all visitors!
